01 Advancements in Molecular Testing The shift from traditional plate culture methods, the "gold standard" for over 30 years, to modern, rapid molecular testing techniques such as PCR and liquid culture methods is a crucial market trend for Legionella testing. Despite their established use, traditional approaches have limitations such as long incubation times (up to 14 days), lack of sensitivity, and high variability in results due to technician-dependent processes. In contrast, newer testing protocols offer significantly faster and more accurate results. For Instance, in November 2022, LuminUltra launched the GeneCount qPCR Corrosion Collection, a suite of DNA-based monitoring tools designed to address microbiologically influenced corrosion (MIC).
02 Growth of Water Treatment and Management Services As industries and facilities increasingly prioritize water quality management, Legionella testing is integral to comprehensive water treatment and safety programs. This trend is particularly pronounced in healthcare, hospitality, and industrial processing sectors, where water systems are complex, and the risks associated with Legionella contamination are high. Regular testing for Legionella bacteria is essential in these environments to ensure compliance with health and safety regulations, protect vulnerable populations, and prevent costly outbreaks. Integrating advanced testing methods into broader water management strategies enhances water systems' overall safety, reliability, and efficiency, driving Legionella testing market growth. For Instance, in May 2022, ChemREADY, a water and wastewater treatment chemical manufacturer, launched a new Legionella testing service and product line to combat the bacteria in building water systems.
June 2026 bioMérieux submitted a 510(k) application to the U.S. FDA for the latest BIOFIRE® FILMARRAY® Gastrointestinal Panels, further expanding its molecular diagnostics platform and strengthening its PCR testing portfolio, including technologies applicable to rapid pathogen detection and environmental microbiology.
May 2026 IDEXX Laboratories expanded its diagnostic testing portfolio with the launch of Taeniid Tapeworm Detection on its Fecal Dx® Antigen Testing Platform, reinforcing its investment in advanced diagnostic technologies alongside its Legiolert® water testing solutions for Legionella detection.
May 2025 The U.S. Centers for Disease Control and Prevention (CDC) updated its guidance on Legionella laboratory testing, reaffirming the combined use of urinary antigen testing (UAT) with culture or molecular (PCR) testing to improve diagnostic accuracy and support outbreak investigations.
April 2025 bioMérieux launched WATCHFIRE™, a molecular wastewater surveillance solution utilizing BIOFIRE® technology to detect pathogens in wastewater. The platform strengthens environmental monitoring capabilities relevant to waterborne pathogen surveillance, including Legionella risk management.